icon
Being food-safe means staying away from preservatives, not having any solvent residues in the product, protecting the microbiome and being suitable for common forms of special diets. With our plant-based, prebiotic and well-kept system, which is free of sugar, lactose and gluten, we bring all these requirements under one roof.

+43 5574 44964

Millennium Park 6A-6890 Lustenau, Austria

img

MSB FRANKINCENSE [100]

  • ID : MSB100.11

116.8 EUR

- In Stock

Cellution® is a microencapsulation technology that enhances the effectiveness of micronutrients, botanicals, and Pharma API by incorporating them into Arabic Gum particles through a unique spray-drying process. The resulting stable hydrocolloid improves the bioavailability of Alpha-lipoic acid, a sulfur-containing fatty acid found in various foods, especially in animal products and plants like spinach and broccoli. Compared to other carriers, Cellution offers advantages such as water solubility, higher bioavailability, versatility, and extended shelf life, amplifying the benefits of MSB.

*Prices per KG
  • From 5 to 20: 116.8 EUR
  • From 21 to 60: 94.9 EUR
  • From 61 to 119: 73 EUR
  • From 120 + 65.7 EUR
add to cart
Categories : M S B Food Supplements

Cellution® employs microencapsulation technology to enhance the functional effects of micronutrients, botanicals, and Pharma API. This technology involves incorporating these substances into the cavities of Arabic Gum particles through a specialized spray drying process, forming a stable hydrocolloid upon the addition of water. This technology enhances the functional powers of frankincense, derived from trees in the balsamic shrub family. Compared to other carriers, Cellution offers advantages such as water solubility, higher bioavailability, versatility, and extended shelf life, amplifying the benefits of MSB frankincense.

• ANTI-INFLAMMATORY AND ANTIPHLOGISTIC EFFECTS

Frankincense, rich in Boswellic acids, exhibits anti-inflammatory properties by deactivating proinflammatory TH1 cytokines and mediators, suppressing the formation of inflammatory cytokines such as leukotrienes, and inhibiting COX-1 formation.

• RHEUMATIC DISEASES MANAGEMENT

Clinical studies demonstrate the effectiveness of frankincense in chronic rheumatoid arthritis, knee osteoarthritis, and joint inflammations, leading to pain reduction and improved mobility.

• GASTROINTESTINAL TRACT INFLAMMATORY DISEASES

Frankincense shows therapeutic efficacy in chronic colitis, ulcerative colitis, and Crohn’s disease, potentially through the inhibition of leukotriene B activity.

• ASTHMA TREATMENT

Studies suggest the potential of frankincense in asthma treatment, showing a 70% improvement in clinical symptoms in a German study.

• COMPREHENSIVE CLINICAL STUDIES

A systematic analysis of 47 studies conducted between 1998 and 2008 supports the efficacy of frankincense in conditions like osteoarthritis, rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and asthma.